摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[4-[(2-pyridinylmethyl)oxy]-3-(1,2,3,4-tetrahydro-6-isoquinolinyl)phenyl]ethanone | 1398696-54-2

中文名称
——
中文别名
——
英文名称
1-[4-[(2-pyridinylmethyl)oxy]-3-(1,2,3,4-tetrahydro-6-isoquinolinyl)phenyl]ethanone
英文别名
1-[4-(Pyridin-2-ylmethoxy)-3-(1,2,3,4-tetrahydroisoquinolin-6-yl)phenyl]ethanone
1-[4-[(2-pyridinylmethyl)oxy]-3-(1,2,3,4-tetrahydro-6-isoquinolinyl)phenyl]ethanone化学式
CAS
1398696-54-2
化学式
C23H22N2O2
mdl
——
分子量
358.44
InChiKey
UHMIDCKSJQAVRH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    27
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    51.2
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • NOVEL COMPOUNDS
    申请人:Atkinson Francis Louis
    公开号:US20120232061A1
    公开(公告)日:2012-09-13
    A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory diseases and/or allergic conditions, in cancer therapy, specifically heme malignancies, and autoimmune conditions.
    化合物公式(I)或其盐;它是脾酪氨酸激酶(SYK)的抑制剂,因此可能用于治疗由肥大细胞、巨噬细胞和B细胞的不适当激活以及相关的炎症反应和组织损伤引起的疾病,例如炎症性疾病和/或过敏症,在癌症治疗中,特别是血液恶性肿瘤和自身免疫疾病。
  • [EN] PYRIDINYL- AND PYRAZINYL -METHYLOXY - ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)<br/>[FR] DÉRIVÉS PYRDINYL- ET PYRAZINYL-MÉTHYLOXY-ARYLE UTILES EN TANT QU'INHIBITEURS DE LA TYROSINE KINASE DE LA RATE (SYK)
    申请人:GLAXO GROUP LTD
    公开号:WO2012123311A1
    公开(公告)日:2012-09-20
    A compound of formula (I) or a salt thereof; which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory diseases and/or allergic conditions, in cancer therapy, specifically heme malignancies, and autoimmune conditions.
    化合物的化学式(I)或其盐;它是脾酪氨酸激酶(SYK)的抑制剂,因此可能用于治疗由于肥大细胞、巨噬细胞和B细胞不适当激活引起的疾病,以及相关的炎症反应和组织损伤,例如炎症性疾病和/或过敏症状,在癌症治疗中,特别是血液恶性肿瘤和自身免疫疾病。
  • PYRIDINYL- AND PYRAZINYL-METHYLOXY-ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)
    申请人:Atkinson Francis Louis
    公开号:US20140005177A1
    公开(公告)日:2014-01-02
    A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory diseases and/or allergic conditions, in cancer therapy, specifically heme malignancies, and autoimmune conditions.
    式(I)的化合物或其盐;它是脾酪氨酸激酶(SYK)的抑制剂,因此可能用于治疗由于肥大细胞、巨噬细胞和B细胞的不适当活化以及相关的炎症反应和组织损伤引起的疾病,例如炎症性疾病和/或过敏性疾病,在癌症治疗中,特别是血液恶性肿瘤和自身免疫疾病中。
  • PYRIDINYL- AND PYRAZINYL -METHYLOXY - ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)
    申请人:Glaxo Group Limited
    公开号:EP2683709A1
    公开(公告)日:2014-01-15
  • TREATMENT FOR VITILIGO
    申请人:Glaxo Group Limited
    公开号:EP3324950A1
    公开(公告)日:2018-05-30
查看更多